Abstract
Small molecules targeting p53 represent an emerging group of potentially useful agents for the improvement of antitumor therapy. These modulators include agents that activate wild-type p53 or reactivate mutant p53 and inhibitors of p53 functions. Preclinical evidences support the interest of combination strategies with conventional antitumor agents.
| Original language | English |
|---|---|
| Pages (from-to) | 856-868 |
| Number of pages | 13 |
| Journal | Mini-Reviews in Medicinal Chemistry |
| Volume | 8 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2008 |
Keywords
- Apoptosis
- Cancer cells
- Drug combination
- Histone deacetylase inhibitors
- Nutlins
- p53
- Pifithrins
- Ubiquitin ligase inhibitors
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Chemistry(all)
- Pharmacology
Fingerprint Dive into the research topics of 'Small molecules targeting p53 to improve antitumor therapy'. Together they form a unique fingerprint.
Cite this
Beretta, G. L., Gatti, L., Benedetti, V., Perego, P., & Zunino, F. (2008). Small molecules targeting p53 to improve antitumor therapy. Mini-Reviews in Medicinal Chemistry, 8(9), 856-868. https://doi.org/10.2174/138955708785132774